Print

OTC Companies 2011: Major Players & Hot Prospects

Published 01/11/2011

Author: Nicholas Hall's Reports

With the OTC market becoming somewhat consolidated after recent M&A activity, including such significant acquisitions as Sanofi’s purchase of Chattem and the Pfizer, Wyeth deal (not to mention the international OTC j-v between P&G and Teva) it is paramount that all OTC marketers evaluate their competitors.

That is why this report, taking a look at the leading and growing companies, and reviewing their OTC focus in terms of brands sales, as well as their latest developments and strategies, is the ultimate guide to anyone in OTC who wants to keep abreast of the competition.

• Bayer • Boehringer Ingelheim • Genomma Lab • GlaxoSmithKline • Hypermarcas
• Johnson & Johnson • Meda • Merck KGaA • MSD • NBTY • Novartis • Otsuka • Pfizer
• Pharmstandart • Procter & Gamble (+ Teva) • Reckitt Benckiser • Sanofi
• Taisho • Takeda (+ Nycomed) • USP

Profiling the above companies, this report gives you an insight into the strengths, weaknesses and overall performance of your competitors, as well as profiling each company according to regional activity.

NOW AVAILABLE AT 50% DISCOUNTED RATE

This is to reflect the fact that the data contained within this report is year-end 2010 data from DB6 2011.

If you would like to purchase particular Country Profiles, please contact
Valerie Tsang.


DescriptionCountry LicenceGlobal LicenceBuy Country LicenceBuy Global Licence 
+ Full Report at 50% Discounted Rate £4,500.00 £6,000.00 Clear
+ Individual Company Profiles at 50% Discounted Rate £283.00 £375.00 Clear